To the mechanism of antiacidotic action of dimefosfon

L. I. Anchikova; Анчикова Л. И.; I. Kh. Valeeva; Валеева И. X.; A. O. Pozdnyak; Поздняк А. О.; L. N. Kurshakova; Куршакова Л. Н.; D. A. Valimukhametova; Валимухаметова Д. А.; I. A. Studentsova; Студенцова И. А.; Kh. S. Khamitov; Хамитов Х. С.; A. O. Wiesel; Визель А. О.

doi:10.17816/kazmj98457

To the mechanism of antiacidotic action of dimefosfon

Authors: Anchikova L.I.¹^,2, Valeeva I.K.¹^,2, Pozdnyak A.O.¹^,2, Kurshakova L.N.¹^,2, Valimukhametova D.A.¹^,2, Studentsova I.A.¹^,2, Khamitov K.S.¹^,2, Wiesel A.O.¹^,2
Affiliations:
1. Lenin Institute for Advanced Medical Training
2. Kurashov Order of the Red Banner of Labor Medical Institute
Issue: Vol 69, No 5 (1988)
Pages: 362-364
Section: Articles
URL: https://ogarev-online.ru/kazanmedj/article/view/98457
DOI: https://doi.org/10.17816/kazmj98457
ID: 98457

Cite item

Full Text

Abstract
Full Text
About the authors
References
Supplementary files
Statistics

Abstract

The aim of this work was to study the effect of the new drug dimefosfon on the acid-base status in patients with autoimmune thyroiditis and to clarify the possible mechanisms of its antiacidotic action. Dimefosfon was administered to patients with autoimmune thyroiditis orally three times at a dose of 100 and 25 mg/kg body weight per day for 3-4 weeks.

Keywords

Kazan Medical archive